Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


26.09.2022

10 AIDS
1 AIDS Res Hum Retroviruses
2 Antimicrob Agents Chemother
1 Antivir Ther
1 Blood
1 BMC Neurol
1 BMC Pediatr
6 Clin Infect Dis
1 Drugs
6 HIV Med
9 J Acquir Immune Defic Syndr
3 J Immunol
1 J Infect Dis
1 J Med Virol
2 Lancet
2 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
2 Nature
2 Pediatr Infect Dis J
1 PLoS Comput Biol
1 PLoS Med
18 PLoS One
1 Proc Natl Acad Sci U S A
1 Science
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. MORAN CA, Oliver NT, Szabo B, Collins LF, et al
    The Association between Comorbidities and COVID-19 Hospitalization among People with HIV differs by Age.
    AIDS. 2022 Sep 16. pii: 00002030-990000000-00112.
    PubMed         Abstract available

  2. LUBEGA J, Kim TO, Airewele G, Grimes A, et al
    Risk factors and prognostic significance of platelet count abnormalities in children with HIV infection on anti-retrovirus therapy.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00116.
    PubMed         Abstract available

  3. JOVANOVIC L, Siljic M, Cirkovic V, Salemovic D, et al
    HIV-1 subtype B spread through cross-border clusters in the balkans: a molecular analysis in view of incidence trends.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00115.
    PubMed         Abstract available

  4. RASMUSSEN LD, Cowan S, Gerstoft J, Kronborg G, et al
    Outcomes following SARS-CoV-2 infection among individuals living with and without HIV; a Danish nationwide cohort study.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00118.
    PubMed         Abstract available

  5. AYTON S, Schwitters A, Mantell JE, Nuwagaba-Biribonwoha H, et al
    Male partner age, viral load, and HIV infection in adolescent girls and young women: Evidence from eight sub-Saharan African countries.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00117.
    PubMed         Abstract available

  6. YOUNGPAIROJ AS, Vanderford TH, Reed MS, Granade TC, et al
    A monoclonal antibody for the detection of the antiretroviral drug emtricitabine.
    AIDS. 2022 Sep 16. pii: 00002030-990000000-00092.
    PubMed         Abstract available

  7. KENG LD, Winston A, Sabin CA
    The global burden of cognitive impairment in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2022 Sep 15. pii: 00002030-990000000-00110.
    PubMed         Abstract available

  8. MYER L, Odayar J, Malaba TR, Allerton J, et al
    Improved virologic outcomes in postpartum women living with HIV referred to differentiated models of care: a randomised controlled trial.
    AIDS. 2022 Sep 16. pii: 00002030-990000000-00113.
    PubMed         Abstract available

  9. SEN S, An H, Oakes J, Eron J, et al
    Effects of early human immunodeficiency virus infection on cerebral white matter blood flow autoregulation.
    AIDS. 2022 Sep 15. pii: 00002030-990000000-00109.
    PubMed         Abstract available

  10. STONE J, Fraser H, Walker JG, Mafirakureva N, et al
    Modelling the impact of HIV and HCV prevention and treatment interventions among people who inject drugs in Kenya.
    AIDS. 2022 Sep 15. pii: 00002030-990000000-00111.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  11. RUIZ-MANRIQUEZ CA, Hernandez-Ruiz VA, Crabtree-Ramirez BE, Amieva H, et al
    A lower CD4+/CD8+ ratio predicts activities of daily living decline among older adults with HIV.
    AIDS Res Hum Retroviruses. 2022 Sep 22. doi: 10.1089/AID.2022.0080.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  12. MTSHALI S, Jacobs BA
    A Comparative Analysis of Physiologically Based Pharmacokinetic Models for Human Immunodeficiency Virus and Tuberculosis Infections.
    Antimicrob Agents Chemother. 2022 Jul 19:e0027422. doi: 10.1128/aac.00274.
    PubMed         Abstract available

  13. LUTERBACH CL, Qiu H, Hanafin PO, Sharma R, et al
    A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
    Antimicrob Agents Chemother. 2022 Sep 20:e0059122. doi: 10.1128/aac.00591.
    PubMed         Abstract available


    Antivir Ther

  14. ARA T, Endo T, Goto H, Kasahara K, et al
    Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor.
    Antivir Ther. 2022;27:13596535221126828.
    PubMed         Abstract available


    Blood

  15. KAVURI SB, Lyapichev KA
    Gelatinous transformation of bone marrow and concomitant fungal infection in a patient with HIV.
    Blood. 2022;140:1325.
    PubMed        


    BMC Neurol

  16. OOKEDITSE O, Ookeditse KK, Motswakadikgwa TR, Masilo G, et al
    Public and outpatients' awareness of calling emergency medical services immediately by acute stroke in an upper middle-income country: a cross-sectional questionnaire study in greater Gaborone, Botswana.
    BMC Neurol. 2022;22:347.
    PubMed         Abstract available


    BMC Pediatr

  17. SACKS E, Katirayi L, Kaeberle B, Mafaune HW, et al
    'The baby will have the right beginning': a qualitative study on mother and health worker views on point-of-care HIV birth testing across 10 sites in Zimbabwe.
    BMC Pediatr. 2022;22:546.
    PubMed         Abstract available


    Clin Infect Dis

  18. MAVE V, Chen L, Ranganathan UD, Kadam D, et al
    Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India.
    Clin Infect Dis. 2022 Jan 4. pii: 6497515. doi: 10.1093/cid/ciab1067.
    PubMed         Abstract available

  19. ELVSTAM O, Malmborn K, Elen S, Marrone G, et al
    Virologic failure following low-level viremia and viral blips during antiretroviral therapy: results from a European multicenter cohort.
    Clin Infect Dis. 2022 Sep 14. pii: 6696999. doi: 10.1093.
    PubMed         Abstract available

  20. ZANNI MV, Foldyna B, McCallum S, Burdo TH, et al
    Sex-Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation among People with HIV in the U.S.
    Clin Infect Dis. 2022 Sep 14. pii: 6697021. doi: 10.1093.
    PubMed         Abstract available

  21. IQBAL K, Dong X, Zhu W, Wiener J, et al
    Decreased HIV diagnosis rates among Black and Hispanic or Latino MSM in U.S. jurisdictions supported by the THRIVE demonstration project, 2014-2019.
    Clin Infect Dis. 2022 Sep 17. pii: 6702535. doi: 10.1093.
    PubMed         Abstract available

  22. BURNS CM, Pung L, Witt D, Gao M, et al
    Development of an HIV Risk Prediction Model Using Electronic Health Record Data from an Academic Health System in the Southern United States.
    Clin Infect Dis. 2022 Sep 19. pii: 6705475. doi: 10.1093.
    PubMed         Abstract available

  23. HERMANS LE, Umunnakwe CN, Lalla-Edward ST, Hebel SK, et al
    Point-Of-Care Tenofovir urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for HIV-1 Infection.
    Clin Infect Dis. 2022 Sep 22. pii: 6711553. doi: 10.1093.
    PubMed         Abstract available


    Drugs

  24. NGAN NTT, Flower B, Day JN
    Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
    Drugs. 2022;82:1237-1249.
    PubMed         Abstract available


    HIV Med

  25. ZHANG Q, Jiao YM, Li G, Zhang LX, et al
    Serum globulin levels are associated with HIV reservoir size and immune restoration during long-term ART.
    HIV Med. 2022 Sep 13. doi: 10.1111/hiv.13393.
    PubMed         Abstract available

  26. LE LT, Price RW, Gisslen M, Zetterberg H, et al
    Correlation between CD4/CD8 ratio and neurocognitive performance during early HIV infection.
    HIV Med. 2022 Sep 22. doi: 10.1111/hiv.13411.
    PubMed         Abstract available

  27. FITZPATRICK C, Richardson D, Sherriff N, Whetham J, et al
    Pilot evaluation of PrEP EmERGE - A novel digital health innovation designed to support sexual health clinics and HIV-PrEP users.
    HIV Med. 2022 Sep 22. doi: 10.1111/hiv.13406.
    PubMed         Abstract available

  28. HIKASA S, Shimabukuro S, Hideta K, Higasa S, et al
    Comparison between the impact of tenofovir alafenamide and that of abacavir on rapid kidney function decline: A retrospective observational study.
    HIV Med. 2022 Sep 20. doi: 10.1111/hiv.13408.
    PubMed         Abstract available

  29. MCGETTIGAN P, Morales DR, Moreno-Martos D, Matin N, et al
    Changing co-morbidity and increasing deprivation among people living with HIV: UK population-based cross-sectional study.
    HIV Med. 2022 Sep 19. doi: 10.1111/hiv.13389.
    PubMed         Abstract available

  30. SHAPIRO AE, Tenforde MW, Chiller TM, Ford N, et al
    An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
    HIV Med. 2022 Sep 19. doi: 10.1111/hiv.13412.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  31. CHAMMARTIN F, Darling K, Abela IA, Battegay M, et al
    CD4:CD8 ratio and CD8 cell count and their prognostic relevance for coronary heart disease events and stroke in antiretroviral treated individuals: The Swiss HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00116.
    PubMed         Abstract available

  32. LEMON TL, Tassiopoulos K, Tsai AC, Cantos K, et al
    Health insurance coverage, clinical outcomes, and health-related quality of life among youth born to women living with HIV.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00120.
    PubMed         Abstract available

  33. PALELLA FJ, Hou Q, Li J, Mahnken J, et al
    Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00121.
    PubMed         Abstract available

  34. MOORE DM, Nanfuka M, Zhang W, Okoboi S, et al
    Limited impact of first-line drug resistance mutations on virologic response among patients receiving second-line anti-retroviral therapy in rural Uganda.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00118.
    PubMed         Abstract available

  35. BOURGI K, Ofner S, Musick B, Griffith B, et al
    Weight Gain among Treatment-naive Persons with HIV Receiving Dolutegravir in Kenya.
    J Acquir Immune Defic Syndr. 2022 Sep 20. pii: 00126334-990000000-00114.
    PubMed         Abstract available

  36. FAINI D, Msafiri F, Munseri P, Bakari M, et al
    The prevalence, incidence and risk factors for HIV among female sex workers - a cohort being prepared for a phase IIb HIV vaccine trial in Dar es Salaam, Tanzania.
    J Acquir Immune Defic Syndr. 2022 Sep 20. pii: 00126334-990000000-00113.
    PubMed         Abstract available

  37. BODLEY N, Dorward J, Naidoo J, Letsoalo M, et al
    Diagnostic accuracy of the Alere Afinion AS100 point-of-care assay to screen for non-communicable diseases amongst people living with HIV.
    J Acquir Immune Defic Syndr. 2022 Sep 20. pii: 00126334-990000000-00115.
    PubMed        

  38. ADEBAJO SB, Adebiyi R, Chama J, Bello S, et al
    Depression and Sexual Stigma are Associated with Cardiometabolic Risk among Sexual and Gender Minorities Living with HIV in Nigeria.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00119.
    PubMed         Abstract available

  39. JACKA BP, Nolen S, Bessey S, Zang X, et al
    Use of pre-exposure prophylaxis (PrEP) to prevent rapid HIV transmission among people who inject drugs (PWID) in rural counties in the United States: A modeling study.
    J Acquir Immune Defic Syndr. 2022 Sep 23. pii: 00126334-990000000-00122.
    PubMed         Abstract available


    J Immunol

  40. MA K, Chai Y, Guan J, Tan S, et al
    Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors.
    J Immunol. 2022 Sep 21. pii: jimmunol.2200191. doi: 10.4049/jimmunol.2200191.
    PubMed         Abstract available

  41. ADDISON MM, Ellis GI, Leslie GJ, Zawadzky NB, et al
    HIV-1-Infected CD4(+) T Cells Present MHC Class II-Restricted Epitope via Endogenous Processing.
    J Immunol. 2022;209:864-873.
    PubMed         Abstract available

  42. NASSER H, Takahashi N, Eltalkhawy YM, Reda O, et al
    Inhibitory and Stimulatory Effects of IL-32 on HIV-1 Infection.
    J Immunol. 2022;209:970-978.
    PubMed         Abstract available


    J Infect Dis

  43. SMITH MSR, Mohan H, Ajaykumar A, Hsieh AYY, et al
    Second-generation HIV integrase inhibitors induce differentiation dysregulation and exert toxic effects in human embryonic stem cell and mouse models.
    J Infect Dis. 2022 Sep 19. pii: 6704757. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  44. SERWIN K, Scheibe K, Horecki M, Aksak-Was B, et al
    Detection of Polish cases of highly virulent subtype B of HIV-1 originating in the Netherlands.
    J Med Virol. 2022 Sep 15. doi: 10.1002/jmv.28154.
    PubMed         Abstract available


    Lancet

  45. LUO R, Fong Y, Boeras D, Jani I, et al
    The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
    Lancet. 2022;400:887-895.
    PubMed         Abstract available

  46. TECHNAU KG, Mazanderani AH
    Point-of-care HIV diagnosis for infants: the outcomes we need to achieve.
    Lancet. 2022;400:864-865.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  47. O'LAUGHLIN K, Tobolowsky FA, Elmor R, Overton R, et al
    Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1190-1195.
    PubMed         Abstract available

  48. PEREZ SM, Panneer N, France AM, Carnes N, et al
    Clusters of Rapid HIV Transmission Among Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2018-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1201-1206.
    PubMed         Abstract available


    N Engl J Med

  49. COLLIE S, Nayager J, Bamford L, Bekker LG, et al
    Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210093.
    PubMed        


    Nature

  50. GONSALVES G
    Monkeypox, COVID-19, AIDS: have we progressed so little?
    Nature. 2022;609:443.
    PubMed        

  51. LEE JH, Sutton HJ, Cottrell CA, Phung I, et al
    Long-primed germinal centres with enduring affinity maturation and clonal migration.
    Nature. 2022 Sep 21. pii: 10.1038/s41586-022-05216.
    PubMed         Abstract available


    Pediatr Infect Dis J

  52. DESAI N, Jenkins CA, Zanoni B, Nmoh A, et al
    High Rates of Viral Suppression and Care Retention Among Youth Born Outside of the United States with Perinatally Acquired HIV.
    Pediatr Infect Dis J. 2022 Sep 8. pii: 00006454-990000000-00187.
    PubMed         Abstract available

  53. DUVENHAGE J, Draper HR, Garcia-Prats AJ, Winckler J, et al
    Hepatocellular Injury in Children Treated for Rifampicin-resistant Tuberculosis: Incidence, Etiology and Outcome.
    Pediatr Infect Dis J. 2022 Sep 6. pii: 00006454-990000000-00179.
    PubMed         Abstract available


    PLoS Comput Biol

  54. WALTARI E, Nafees S, McCutcheon KM, Wong J, et al
    AIRRscape: An interactive tool for exploring B-cell receptor repertoires and antibody responses.
    PLoS Comput Biol. 2022;18:e1010052.
    PubMed         Abstract available


    PLoS Med

  55. EDMONDS A, Brazier E, Musick BS, Yotebieng M, et al
    Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study.
    PLoS Med. 2022;19:e1004089.
    PubMed         Abstract available


    PLoS One

  56. SHRIVASTAV S, Lee H, Okamoto K, Lu H, et al
    HIV-1 Vpr suppresses expression of the thiazide-sensitive sodium chloride co-transporter in the distal convoluted tubule.
    PLoS One. 2022;17:e0273313.
    PubMed         Abstract available

  57. DELPORT A, Tabana H, Knight L, Wouters E, et al
    The co-occurrence of the SAVA syndemic, depression and anxiety as barriers to antiretroviral therapy adherence among sub-Saharan Africa population groups: A scoping review protocol.
    PLoS One. 2022;17:e0274614.
    PubMed         Abstract available

  58. LIGHTNER JS, Barnhart T, Shank J, Adams D, et al
    Outcomes of the KC life 360 intervention: Improving employment and housing for persons living with HIV.
    PLoS One. 2022;17:e0274923.
    PubMed         Abstract available

  59. DUNNE TF, Chandna J, Majo F, Tavengwa N, et al
    Performance of the UNICEF/UN Washington Group tool for identifying functional difficulty in rural Zimbabwean children.
    PLoS One. 2022;17:e0274664.
    PubMed         Abstract available

  60. KARONEY MJ, Koech MK, Njiru EW, Owino Ong'or WD, et al
    Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya.
    PLoS One. 2022;17:e0273183.
    PubMed         Abstract available

  61. ARENAS-PINTO A, Judd A, Melvin D, Le Prevost M, et al
    Learning and memory function in young people with and without perinatal HIV in England.
    PLoS One. 2022;17:e0273645.
    PubMed         Abstract available

  62. TUAN ABDULLAH TN, Mat Min R, Abdullah SS, Hossain M, et al
    Counselling experiences among men having sex with men and living with HIV in Malaysia.
    PLoS One. 2022;17:e0274251.
    PubMed         Abstract available

  63. ACHARYA S, Deshpande P, Asirvatham ES, Palkar A, et al
    Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India.
    PLoS One. 2022;17:e0273970.
    PubMed         Abstract available

  64. POON PK, Wong NS, Leung WS, Wong BC, et al
    The differential impacts of early detection and accelerated antiretroviral therapy on the epidemiologic trend of sexually acquired HIV infection in Hong Kong.
    PLoS One. 2022;17:e0274498.
    PubMed         Abstract available

  65. JOHNSTON LG, Nguyen VK, Balakrishnan S, Lwamba C, et al
    Deriving and interpreting population size estimates for adolescent and young key populations at higher risk of HIV transmission: Men who have sex with men and females who sell sex.
    PLoS One. 2022;17:e0269780.
    PubMed         Abstract available

  66. MWAMUYE IC, Karanja S, Msanzu JB, Adem A, et al
    Factors associated with poor outcomes among people living with HIV started on anti-retroviral therapy before and after implementation of "test and treat" program in Coastal Kenya.
    PLoS One. 2022;17:e0270653.
    PubMed         Abstract available

  67. ZIBAKO P, Tsikai N, Manyame S, Ginindza TG, et al
    Cervical cancer management in Zimbabwe (2019-2020).
    PLoS One. 2022;17:e0274884.
    PubMed         Abstract available

  68. FOKAM J, Alteri C, Colagrossi L, Genevieve AM, et al
    Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000).
    PLoS One. 2022;17:e0273818.
    PubMed         Abstract available

  69. PIETA M, Rzeszutek M
    Trajectories of posttraumatic growth and posttraumatic depreciation: A one-year prospective study among people living with HIV.
    PLoS One. 2022;17:e0275000.
    PubMed         Abstract available

  70. PRADUBKHAM T, Suwanpimolkul G, Gross AE, Nakaranurack C, et al
    Intravenous to oral transition of antibiotics for gram-negative bloodstream infection at a University hospital in Thailand: Clinical outcomes and predictors of treatment failure.
    PLoS One. 2022;17:e0273369.
    PubMed         Abstract available

  71. OKELLO CD, Shih AW, Angucia B, Kiwanuka N, et al
    Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda.
    PLoS One. 2022;17:e0275126.
    PubMed         Abstract available

  72. MOYO K, Igaba N, Wose Kinge C, Chasela C, et al
    Voluntary medical male circumcision in selected provinces in South Africa: Outcomes from a programmatic setting.
    PLoS One. 2022;17:e0270545.
    PubMed         Abstract available

  73. RAO A, Moorhouse L, Maswera R, Dadirai T, et al
    Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic.
    PLoS One. 2022;17:e0273776.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  74. VILLABONA-ARENAS CJ, Hue S, Baxter JAC, Hall M, et al
    Using phylogenetics to infer HIV-1 transmission direction between known transmission pairs.
    Proc Natl Acad Sci U S A. 2022;119:e2210604119.
    PubMed         Abstract available


    Science

  75. TEGALLY H, San JE, Cotten M, Moir M, et al
    The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance.
    Science. 2022 Sep 15:eabq5358. doi: 10.1126/science.abq5358.
    PubMed         Abstract available


    Virology

  76. HANSEN T, Baris J, Zhao M, Sutton RE, et al
    Cell-based and cell-free firefly luciferase complementation assay to quantify Human Immunodeficiency Virus type 1 Rev-Rev interaction.
    Virology. 2022;576:30-41.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: